Many different types of cells in the body have a tiny projection known as a primary cilium. These cilia act like little signaling hub that can capture information about a cell’s environment and relay it to the cell, ultimately coordinating some cellular responses. The functions of cilia are well known in a few cases, such as in development, where they are crucial to the regulation of certain processes; or in some disorders called ciliopathies, in which genetic mutations lead to ciliary dysfunction and human disease.
Category: biotech/medical – Page 31
Interview With RAADFest Creator, James Strole
Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhDDiscount Links/Affiliates: Blood testing (where I get the majority of my labs): https://www.u…
Nanoplastics can disrupt gut microbes in mice by interfering with extracellular vesicle-delivered microRNA
Nanoplastics can compromise intestinal integrity in mice by altering the interactions between the gut microbiome and the host, according to a paper in Nature Communications. The study explores the complex interactions of nanoplastics with the gut microenvironment in mice.
Nanoplastics are pieces of plastic less than 1,000 nanometers in diameter, which are created as plastics degrade. Previous research has suggested that nanoplastic uptake can disrupt the gut microbiota; however, the underlying mechanism behind this effect is poorly understood.
Researcher Wei-Hsuan Hsu and colleagues used RNA sequencing, transcriptomic analysis and microbial profiling to analyze the effects of polystyrene nanoplastics on the intestinal microenvironment when ingested in mice. They found that nanoplastic accumulation in the mouse intestine was linked to altered expression of two proteins involved in intestinal barrier integrity (ZO-1 and MUC-13), which could disrupt intestinal permeability.
Discovery of two new genetic disorders improves diagnoses for patients with neurodevelopmental conditions
The discovery of two new genetic disorders comes from a study delivered through the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Center (BRC) and The University of Manchester and could provide answers for several thousands of people with neurodevelopmental conditions around the world.
Since the breakthrough, 18-year-old Rose Anderson from Stretford in Manchester has received a diagnosis of one of the newly discovered conditions.
Rose has been known to the team at the Manchester Center for Genomic Medicine at Manchester University NHS Foundation Trust (MFT) for nearly her whole life, although a precise diagnosis for her seizures and developmental delay has proved difficult to find.
Stem cell platform aims to recreate brain’s immune system using lab-grown human microglia cells
Microglia are a specialized type of immune cell that accounts for about 10% of all cells within the brain and spinal cord. They function by eliminating infectious microbes, dead cells, and aggregated proteins, as well as soluble antigens that may endanger the brain and, during development, also help shape neural circuits enabling specific brain functions.
When microglia don’t function properly, they can trigger neuroinflammation and fail to clear away damaged cells and harmful protein clumps—such as the neurofibrillary tangles and amyloid plaques seen in Alzheimer’s disease. This contributes to numerous neurodegenerative diseases, including Alzheimer’s, Parkinson’s and Huntington’s disease, as well as amyotrophic lateral sclerosis (ALS), multiple sclerosis, and other disorders. In fact, neuroinflammation can occur even before proteins start to form pathogenic aggregates and, in turn, accelerates protein aggregation.
Researchers and drug developers aiming to better understand and target microglia functions in the brain are challenged by the fact that human microglia can only be obtained through biopsies, and rodents’ microglia differ from their human counterparts in many critical features. This supply issue prompted them to work on methods to create microglia in the culture dish using stem cells as a starting point. However, to date, this process has remained inefficient, and requires weeks to complete at significant costs.
Machine learning helps ease the jitters of high-power lasers
Researchers at the Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) have made a breakthrough in laser technology by using machine learning (ML) to help stabilize a high-power laser.
This advancement, spearheaded by Berkeley Lab’s Accelerator Technology & Applied Physics (ATAP) and Engineering Divisions, promises to accelerate progress in physics, medicine, and energy. The researchers report their work in the journal High Power Laser Science and Engineering.
Tracing brain circuits that tell us when to eat—and when to stop
Scientists know the stomach talks to the brain, but two new studies from Rutgers Health researchers suggest the conversation is really a tug-of-war, with one side urging another bite, the other signaling “enough.”
Together, the papers in Nature Metabolism and Nature Communications trace the first complementary wiring diagram of hunger and satiety in ways that could refine today’s blockbuster weight-loss drugs and blunt their side effects.
One study, led by Zhiping Pang of Robert Wood Johnson Medical School’s Center for NeuroMetabolism, pinpointed a slender bundle of neurons that runs from the hypothalamus to the brainstem.
Dual-laser photothermal therapy strategy improves breast cancer treatment while reducing healthy tissue damage
Breast cancer is the most prevalent malignancy among women worldwide. Phototheranostics—an approach that uses light both to detect and treat cancerous lesions—has drawn growing attention due to its potential advantages, including light-triggered, non-invasive real-time diagnosis and simultaneous in situ therapy.
One promising strategy in light-based cancer treatment is photothermal therapy (PTT), which employs photothermal agents—ideally with tumor-targeting capability—to convert light irradiation into localized heat. However, challenges remain in the clinical translation of PTT, particularly the risks of overheating and damaging healthy tissue, as well as the potential failure to effectively ablate tumors.
In a study published in PNAS, a team led by Zhang Pengfei from the Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Sciences, in collaboration with Jong Seung Kim from Korea University, Jonathan L. Sessler from the University of Texas at Austin, and Zhou Hui from the Nanjing University of Posts and Telecommunications, developed a dual-laser PTT (DLPTT) strategy for breast cancer therapy.
